CD274 and cancer: Increased NK cell susceptibility also reflects the ability of the tumor to release apoptosis-promoting factors (programmed death receptor ligand, PDL-1), which can abolish several effector cell functions within the tumor microenvironment as detected on PD-1+ NK cells in cancer patients (58, 59).